GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bafna Pharmaceuticals Ltd (BOM:532989) » Definitions » Long-Term Capital Lease Obligation

Bafna Pharmaceuticals (BOM:532989) Long-Term Capital Lease Obligation : ₹0 Mil (As of Mar. 2025)


View and export this data going back to 2008. Start your Free Trial

What is Bafna Pharmaceuticals Long-Term Capital Lease Obligation?

Bafna Pharmaceuticals's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2025 was ₹0 Mil.


Bafna Pharmaceuticals Long-Term Capital Lease Obligation Historical Data

The historical data trend for Bafna Pharmaceuticals's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bafna Pharmaceuticals Long-Term Capital Lease Obligation Chart

Bafna Pharmaceuticals Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Bafna Pharmaceuticals Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bafna Pharmaceuticals  (BOM:532989) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Bafna Pharmaceuticals Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Bafna Pharmaceuticals's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


Bafna Pharmaceuticals Business Description

Traded in Other Exchanges
Address
Thambu Chetty Street, New No. 68, Old No.299, Bafna Towers, Chennai, TN, IND, 600001
Bafna Pharmaceuticals Ltd is an India-based pharmaceutical company. It is principally engaged in the manufacturing and marketing of drugs and medicines. The company sells its products in India and international regions. The company has only one Segment of Business namely Pharmaceuticals.

Bafna Pharmaceuticals Headlines

No Headlines